W.H.O. chooses three African countries to test first malaria vaccine

W.H.O. chooses three African countries to test first malaria vaccine

The World Health Organization (W.H.O.) announced on Monday that three African countries, viz. Ghana, Kenya, and Malawi, have been chosen for testing the world’s first malaria vaccine.

The three African nations will kick off piloting the injectable malaria vaccine sometime in 2018 with hundreds of thousands of young kids, who are particularly at risk due to the mosquito-borne deadly disease.

Dr. Matshidiso Moeti, the health agency’s regional director for Africa, said that the injectable vaccine is partial effective and has the potential to save thousands of lives if used in combination with existing measures.

The vaccine is being developed by pharmaceuticals giant GSK, which will provide the vaccine for free of charge for the planned pilot program.

Speaking on the topic, Moeti said, “We are very appreciative that GSK … provide this for free of charge for this pilot. And the vaccine will be assessed as the complementary intervention in Africa that can be added to our existing tool box of proven preventive diagnostic and treatment measures.”

Malaria remains one of biggest health challenges, infecting more than two hundred million individuals every year worldwide and leaving nearly half a million dead. Currently, insecticides and bed netting are the chief protection against the potentially deadly disease.


Whether you want to ask us a question, would like to solve a problem, or just give us a suggestion, you’ll find many ways to contact us right here.

Email: editor@norcal.news

Phone: (916) 225-9835

Fax: (916) 225-9845


Subscribe and get the latest updates, news and more...